 "Covaxin, Covishield, serum institute of india, bharat biotech")
Indian health care workers who were administered Covishield have shown better antibody response than the Covaxin recipients, revealed a recent study.
The study, published in an online archive for unpublished manuscripts in medical sciences medRxiv, showed that after two shots of the vaccines, 98 per cent recipients of Covishield showed antibody response, while the same was 80 per cent among Covaxin recipients.
The study published by a group of doctors - Awadhesh Kumar Singh, Sanjeev Ratnakar Phatak, Ritu Singh, Kingshuk Bhattacharjee, Nagendra Kumar Singh, Arvind Gupta, and Arvind Sharma – has not been peer-reviewed yet. The researchers have declared no competing interest
